Jun 29, 2023 8:00am EDT RenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGem™ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer
Jun 01, 2023 8:30am EDT RenovoRx Initiates Patient Enrollment at University of Texas Southwestern Medical Center for Pivotal Phase III TIGeR-PaC Clinical Trial
May 25, 2023 8:30am EDT RenovoRx Announces Late-Breaking Oral Presentation at 2023 ESMO World Congress on Gastrointestinal Cancer
May 15, 2023 8:30am EDT RenovoRx Reports First Quarter 2023 Financial Results and Operational Highlights
Apr 28, 2023 8:30am EDT RenovoRx to Participate in the Aegis Capital Virtual Conference on May 3, 2023
Apr 27, 2023 8:30am EDT RenovoRx Appoints Former Chief Medical Officer of Schering-Plough, Robert J. Spiegel, MD, FACP, to Board of Directors
